Research News and Research

RSS

Brain’s immune cells play key role in maintaining stability of neuronal networks in Alzheimer's disease

Researchers at Trinity College Dublin have discovered that microglia – the main immune cells of the brain – play a critical role in maintaining the stability of neuronal networks in Alzheimer's disease.

15 Jul 2026

AI model predicts effective immunotherapy combinations for liver cancer

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular carcinoma (HCC) would most benefit from combination treatment using immunotherapy and a targeted therapy that blocks the growth signals that the tumor depends on.

15 Jul 2026

Self-assembling antibody drugs successfully target multiple cancer receptors

Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drug, often given to patients for whom standard chemotherapy has not worked.

15 Jul 2026

New machine learning model improves cholesterol calculation accessibility

The Martin-Hopkins equation to assess low-density lipoprotein (LDL) cholesterol levels in blood samples has been used by laboratories in the U.S. and other countries to guide efforts to lower cardiovascular disease risk.

15 Jul 2026

Ketogenic diet may increase small intestine cancer risk in mice

A high-fat, low-carbohydrate diet, also called a ketogenic diet, can help some people lose weight by forcing their bodies to burn fat for fuel instead of sugar.

15 Jul 2026

Low-nicotine cigarettes do not cause increased compensatory smoking

People who switch to cigarettes with dramatically reduced nicotine levels are unlikely to smoke more cigarettes or inhale more smoke to compensate for the lower nicotine content, according to a new study led by researchers at Wake Forest University School of Medicine and published in JAMA Network Open.

15 Jul 2026

New diagnostic blood test improves food allergy detection accuracy

Allergies can be minor or life-threatening, and current diagnostic blood tests are not always adequate at determining which substances patients need to avoid to prevent a reaction.

15 Jul 2026

Targeted nanoparticles destroy tumor cells by triggering cuproptosis

A promising cancer treatment strategy called cuproptosis, which uses copper-dependent cell death to eliminate tumor cells, faces a major challenge: many approaches require adding external copper, potentially increasing toxicity beyond the tumor.

15 Jul 2026

New photoswitchable drugs restore light perception in blind animals

Blinding diseases caused by the degeneration of photoreceptors, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP), affect 200 million people worldwide and represent the leading causes of visual impairment and blindness.

15 Jul 2026

Healthcare barriers impact survival rates for adult congenital heart disease

People with congenital heart disease living in states with low household incomes and limited access to health insurance and the specialized care they need may be more likely to become disabled or die from congenital heart disease, according to new, independent research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

15 Jul 2026

AbbVie Strengthens Immunology Leadership with $10.9 Billion Apogee Therapeutics Acquisition

AbbVie's strategic acquisition of Apogee Therapeutics highlights its commitment to advancing immunology and developing next-generation treatments for patients.

From 10th Dermatology Drug Development Summit 15 Jul 2026

Designing the AI-Enabled Life Sciences Workforce Summit Europe

AI's impact on drug discovery and manufacturing raises critical workforce questions, driving life sciences organizations to rethink skills and leadership.

From Designing the AI-Enabled Life Sciences Workforce Summit Europe 15 Jul 2026

Thermo Fisher Scientific launches GENESYS™ G5 suite of spectrophotometers, combining UV-Vis performance with expandable software and workflow flexibility

Thermo Fisher Scientific has launched the Thermo Scientific™GENESYS™ G5 series of Visible and UV-Visible spectrophotometers, designed to help laboratories standardize workflows, simplify routine testing, and expand analytical capabilities as requirements evolve.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 15 Jul 2026

Study sheds light on the prognostic value of blood test for predicting cognitive impairment risk

A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged around the extent to which such tests can accurately predict whether a cognitively healthy individual will go on to develop cognitive impairment-a key symptom of Alzheimer's disease.

15 Jul 2026